Mixed
Long-term metformin treatment (up to 2,000 mg/day) significantly alters gut microbiota composition by increasing Escherichia coli and Ruminococcus torques while decreasing Intestinibacter bartlettii and Roseburia species, effects that persist for at least 12 months.
If you take metformin, expect your gut bacteria to change in a specific way: more E. coli and Ruminococcus torques, less Intestinibacter bartlettii and Roseburia. These changes don't just happen briefly; they stick around for at least a year. Importantly, these changes happen regardless of how much weight you lose, meaning the drug itself is driving this shift. While this might sound concerning because E. coli can be harmful, in this context, it is linked to increased production of short-chain fatty acids like acetate, which may help improve insulin sensitivity. If you experience stomach upset, talk to your doctor about slow dose titration.
Only metformin treatment significantly altered microbiota composition. Compared with control, metformin treatment increased amplicon sequence variants for Escherichia (confirmed as Escherichia coli by metagenomic sequencing) and Ruminococcus torques and decreased Intestinibacter bartlettii at both 6 and 12 months and decreased the genus Roseburia, including R. faecis and R. intestinalis, at 12 months.
Why this rating
Randomized controlled trial with a large sample size (n=121) and long duration (12 months), though limited to cancer survivors.
Source
Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial
Noel T. Mueller et al. · Diabetes Care · 2021
DOI 10.2337/dc20-2257
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →